Congresso Congiunto AIM – ASNP

Fascicolo 4-2020

Scarica il PDF del Fascicolo

Editorial

25th Anniversary of the Founding of the World Muscle Society (1995-2020). The Contribution of Prof. Giovanni Nigro (1931-2017)

Luciano Merlini

Giovanni Nigro A note of remembrance

Lefkos T Middleton, MD, FRCP

Original article

Causes of clinical variability in Duchenne and Becker muscular dystrophies and implications for exon skipping therapies

Eric P. Hoffman
DOI 10.36185/2532-1900-020

Giovanni Nigro and the Naples’s school: historical contribution to the knowledge of heart involvement in Duchenne/Becker muscular dystrophies

Luisa Politano
DOI 10.36185/2532-1900-021

Impaired myocardial strain in early stage of Duchenne muscular dystrophy: its relation with age and motor performance

Lilia Oreto^1,2, Gian Luca Vita³, Giuseppe Mandraffino^{^1,4}, Scipione Carerj², Maria Pia Calabrò⁵, Roberta Manganaro², Maurizio Cusmà-Piccione², Maria Chiara Todaro^2,6, Maria Sframeli³, Maria Cinquegrani⁴, Antonio Toscano⁷, Giuseppe Vita^3,7, Sonia Messina^3,7, Concetta Zito²
DOI 10.36185/2532-1900-022

Quadriceps muscle strength in Duchenne muscular dystrophy and effect of corticosteroid treatment

Luciano Merlini¹, Ilaria Cecconi², Antonia Parmeggiani², Duccio Maria Cordelli², Ada Dormi³
DOI 10.36185/2532-1900-023

LGMD. Identification, description and classification

Corrado Angelini
DOI 10.36185/2532-1900-024

Alpha-sarcoglycanopathy presenting as myalgia and hyperCKemia in two adults with a long-term follow-up. Case reports

Claudia Dosi¹, Anna Rubegni1¹ Denise Cassandrini¹, Alessandro Malandrini², Lorenzo Maggi³, M. Alice Donati⁴, Filippo M. Santorelli¹
DOI 10.36185/2532-1900-025

Myotonic dystrophy type 2: the 2020 update

Giovanni Meola^1,2
DOI 10.36185/2532-1900-026

Late-onset myopathies: clinical features and diagnosis

Marianne de Visser
DOI 10.36185/2532-1900-027

Panorama of the distal myopathies

Marco Savarese^1,2, Jaakko Sarparanta^1,2, Anna Vihola^1,2,3, Per Harald Jonson^1,2, Mridul Johari^1,2, Salla Rusanen1^1,2, Peter Hackman^1,2, Bjarne Udd^1,2,4
DOI 10.36185/2532-1900-028

Core myopathies – a short review

Haluk Topaloglu
DOI 10.36185/2532-1900-029

Dominant or recessive mutations in the RYR1 gene causing central core myopathy in Brazilian patients

Leonardo Galleni Leão¹, Lucas Santos Souza¹, Letícia Nogueira¹, Rita de Cássia Mingroni Pavanello¹, Juliana Gurgel-Giannetti², Umbertina C Reed³, Acary S.B. Oliveira⁴, Thais Cuperman⁴, Ana Cotta⁵, Julia FPaim⁵, Mayana Zatz¹, Mariz Vainzof¹
DOI 10.36185/2532-1900-030

The changing spectrum of drug-induced myopathies

Frank L. Mastaglia
DOI 10.36185/2532-1900-031

Inflammatory myopathies: update on diagnosis, pathogenesis and therapies, and COVID-19-related implications

Marinos C. Dalakas
DOI 10.36185/2532-1900-032

Giant cell myositis and myocarditis revisited

Piraye Oflazer
DOI 10.36185/2532-1900-033

The impact of SARS-CoV-2 on skeletal muscles

Maria Rita De Giorgio^1,2, Stefania Di Noia^2,3, Cinzia Morciano^1,2, Diana Conte^4,5
DOI 10.36185/2532-1900-034

The correlation between cardiac and skeletal muscle pathology in animal models of idiopathic inflammatory myopathies

Francesco Prisco, Serenella Papparella, Orlando Paciello
DOI 10.36185/2532-1900-035

Cutaneous and metabolic defects associated with nuclear abnormalities in a transgenic mouse model expressing R527H lamin A mutation causing mandibuloacral dysplasia type A (MADA) syndrome

Maria Rosaria D’Apice¹, Angela De Dominicis¹, Michela Murdocca², Francesca Amati², Annalisa Botta², Federica Sangiuolo^1,2, Giovanna Lattanzi⁴, Massimo Federici⁴, Giuseppe Novelli^1,2,5,6
DOI 10.36185/2532-1900-036